Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05425940 |
|---|---|
| Brief Title: | Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer (STELLAR-303) |
| First Submitted : | June 16, 2022 |
| First Submitted that Met QC Criteria : | June 16, 2022 |
| First Posted : | June 21, 2022 |
| Last Update Submitted that Met QC Criteria : | March 18, 2024 |
| Last Update Posted : | March 19, 2024 |